NCT04420949

Brief Summary

This is a preliminary study to determine the reliability and validity of new tests of orientation and balance, as well as to test the effects of a new treatment for visually induced dizziness. Tests involve determining vertical alignment. The treatment is task-based and involves focusing attention on internal body sensations to help improve the sense of upright. Testing is done twice before and twice after treatment, which is provided twice-weekly during a three-week period between testing. The total time participants are involved in the study is approximately six weeks.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
10

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Mar 2021

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 15, 2020

Completed
25 days until next milestone

First Posted

Study publicly available on registry

June 9, 2020

Completed
9 months until next milestone

Study Start

First participant enrolled

March 19, 2021

Completed
3 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2021

Completed
1.6 years until next milestone

Results Posted

Study results publicly available

January 25, 2023

Completed
Last Updated

June 15, 2023

Status Verified

May 1, 2023

Enrollment Period

3 months

First QC Date

May 15, 2020

Results QC Date

June 29, 2022

Last Update Submit

May 17, 2023

Conditions

Keywords

verticalitypostural balancevisual dependence

Outcome Measures

Primary Outcomes (4)

  • Rod and Disk Test (RDT) Mean Performance

    An image of a rod will be shown in the central portion of the visual field. The surrounding virtual environment will be void. A batch of rod angles will be predetermined. This assessment will be completed using an Oculus Rift and without any reference to external visual cues. Only binocular testing will be completed. The average value for performance in each position will be used in data analysis. The mean of absolute value of the error in rod alignment measured in degrees for each body position tested will be used as the measurement variable for this outcome, and the primary outcome is the absolute value for mean performance in upright. In a prior study, the mean performance in this population is 0.39 (sd 0.8). Higher scores indicate subjective visual vertical alignment that is farther away from earth vertical.

    Visit 1 (Week 1), Visit 2 (Week 2), Visit 7 (Week 4), and Visit 8 (Week 5)

  • Multisensory Balance Evaluation (MBE) as Measured by the Intersection Point Height

    This test is designed to assess balance during quiet standing in different sensory conditions. Participants perform one trial (lasting 30 seconds) of each condition. All trials are performed while standing on a force plate with the feet in a self-selected, comfortable position. The visual environment is controlled using an Oculus Rift. The surface conditions are either non-compliant or compliant. The frequency-dependent height of the Intersection Point (IP) of the ground reaction force is the main metric. The overall height of the IP curve obtained while the participant stands on a firm surface with their eyes open is the primary outcome. The height of IP ranges from 0 to 4.0, and higher values represent greater stability.

    Visit 1 (Week 1), Visit 2 (Week 2), Visit 7 (Week 4), and Visit 8 (Week 5)

  • Subjective Visual Vertical (SVV) Mean Performance

    An image of a rod will be shown in the central portion of the visual field. The surrounding virtual environment will be void. A batch of rod angles will be predetermined. This assessment will be completed using an Oculus Rift and without any reference to external visual cues. Only binocular testing will be completed. The average value for performance in each position will be used in data analysis. The mean of absolute value of the error in rod alignment measured in degrees for each body position tested will be used as the measurement variable for this outcome, and the primary outcome is the absolute value for mean performance in upright. In a prior study, the mean performance in this population is 0.39 (sd 0.8). Higher scores indicate subjective visual vertical alignment that is farther away from earth vertical.

    Visit 1 (Week 1), Visit 2 (Week 2), Visit 7 (Week 4), and Visit 8 (Week 5)

  • Rod and Frame Test (RFT) Mean Performance

    An image of a rod will be projected inside a tilted frame within the central portion of the visual field. The surrounding virtual environment will be void. The frame will be tilted by +/- 20° in the frontal plane. A batch of rod angles will be predetermined. This assessment will be completed using an Oculus Rift and without reference to external visual cues. Only binocular testing will be completed. The average value for performance in each position will be used in data analysis. The mean of absolute value of the error in rod alignment measured in degrees for each body position tested will be used as the measurement variable for this outcome, and the primary outcome is the absolute value for mean performance in upright. In a prior study, mean performance in this population is 6.51 (sd 7.8). Higher values indicate greater deviations of perceived vertical from earth vertical.

    Visit 1 (Week 1), Visit 2 (Week 2), Visit 7 (Week 4), and Visit 8 (Week 5)

Secondary Outcomes (2)

  • Vision-related Dizziness Questionnaire (VRDQ) Total Score

    Visit 1 (Week 1), Visit 2 (Week 2), Visit 7 (Week 4), and Visit 8 (Week 5)

  • Dizziness Handicap Inventory (DHI) Total Score

    Visit 1 (Week 1), Visit 2 (Week 2), Visit 7 (Week 4), and Visit 8 (Week 5)

Other Outcomes (5)

  • Activities-specific Balance Confidence Scale (ABCS) Average Score

    Visit 1 (Week 1), Visit 2 (Week 2), Visit 7 (Week 4), and Visit 8 (Week 5)

  • Vestibular Activities and Participation Measure (VAPM) Average Score

    Visit 1 (Week 1) and Visit 8 (Week 5)

  • Vestibular Rehabilitation Benefits Questionnaire (VRBQ) Total Score at the End of the Trial

    Visit 1 (Week 1) and Visit 8 (Week 5)

  • +2 more other outcomes

Study Arms (2)

Healthy

EXPERIMENTAL

Healthy adults with visually-induced dizziness with undergo the testing and treatment.

Behavioral: Sensory re-weighting

Vestibular-impaired

EXPERIMENTAL

Adults with unilateral or bilateral, peripheral vestibular loss who also have visually-induced dizziness with undergo the testing and treatment.

Behavioral: Sensory re-weighting

Interventions

During training, sensory re-weighting is driven by priming upregulation of somatosensory cues. Two rounds of training, each lasting 15 minutes and block-randomized in sets of 10 trials, are conducted per training visit. In each training trial, participants must determine the direction of gravity and then indicate if the rod being displayed is aligned with gravity or if it needs to rotate clockwise or counterclockwise for that to be so. Participants will be instructed to pay attention to what they feel from their feet, legs, and gut during training and to use that pressure, stretch, movement, and muscle tension feedback to help them sense gravity. Immediate auditory and non-orienting, visual feedback is provided after each trial. A staircase method is used to adapt the level of difficulty based on response accuracy. After two consecutive correct responses, the difficulty increases. After each incorrect response, the difficulty decreases. This process is repeated in each round.

HealthyVestibular-impaired

Eligibility Criteria

Age18 Years - 79 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • have normal self-reported cognitive function
  • speak English fluently
  • weigh less than 225 pounds and be less than 6'4"
  • be able to support their body weight in an upright posture for 15 minutes at a time
  • be able to follow the guidelines regarding permitted and prohibited additional treatments outlined in this protocol

You may not qualify if:

  • be pregnant or planning to become pregnant while in "on study" status
  • have best-corrected visual acuity \> 20/70
  • have a self-reported, uncompensated, binocular vision abnormality, such as strabismus, amblyopia, or diplopia
  • have peripheral neuropathy
  • have a self-reported history of frequent syncope (\>1/month)
  • Participants with Visually-induced Dizziness:
  • have self-reported symptoms of visually-induced dizziness
  • have normal self-reported cognitive function
  • speak English fluently
  • weigh less than 225 pounds and be less than 6'4"
  • be able to support their body weight in an upright posture for 15 minutes at a time
  • be able to follow the guidelines regarding permitted and prohibited additional treatments outlined in this protocol
  • be participating in vestibular and balance rehabilitation therapy and/or be pregnant or planning to become pregnant while in "on study" status
  • have best-corrected visual acuity \> 20/70
  • have a self-reported, uncompensated, binocular vision abnormality, such as strabismus, amblyopia, or diplopia
  • +1 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Wisconsin-Madison

Madison, Wisconsin, 53705, United States

Location

MeSH Terms

Conditions

DizzinessVertigoMotion Sickness

Condition Hierarchy (Ancestors)

Sensation DisordersNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsVestibular DiseasesLabyrinth DiseasesEar DiseasesOtorhinolaryngologic DiseasesNervous System Diseases

Limitations and Caveats

Due to Covid-19 restrictions, enrollment in this study was lower than planned.

Results Point of Contact

Title
Dr. Kreg Gruben
Organization
University of Wisconsin - Madison

Publication Agreements

PI is Sponsor Employee
Yes

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Masking Details
It is not possible to mask this behavioral intervention. The study team small; thus, masking of the study team is also not possible.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: The study will be conducted in three phases. The first phase is for baseline testing. The second phase is when treatment occurs. The third phase is for follow up testing. Participants will be tested twice during the baseline and follow up phases. Six treatment sessions will occur during the treatment phase.
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 15, 2020

First Posted

June 9, 2020

Study Start

March 19, 2021

Primary Completion

June 30, 2021

Study Completion

June 30, 2021

Last Updated

June 15, 2023

Results First Posted

January 25, 2023

Record last verified: 2023-05

Data Sharing

IPD Sharing
Will not share

There is not plan to share individual participant data.

Locations